RxDoctor Payments Data

Michael Moore

Neurological Surgery · Reno, NVNPI 1306136452

Payments from drug & device makers

What this record shows

This record is dominated by food and beverage: $1,302 of the $2,088 with a category attached, or 62.3%. Medtronic accounts for 81.8% of it on its own, with 8 other manufacturers making up the rest. Reporting peaked in 2024 at $1,258 and has fallen 92.7% since, to $92 in 2025. That places this record below the midpoint for neurological surgery clinicians in NV, where the typical reported total is $6,847.

$2,088in general payments, 2019–2025

Across 33 payments — averaging $63.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$2K
  • Monteris Medical Corporation$146
  • Medexus Pharma, Inc.$101
  • Surgical Theater. Inc.$34
  • Stryker$27
  • Integra Lifesciences Corporation$23
  • plus $50 from 3 others

What the payments were for

  • Travel & lodging$78638%
  • Food & beverage$1,30262%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,088 in reported general payments places this provider in the 35th percentile of 45 neurological surgery providers in Nevada.

See all neurological surgery providers in Nevada

Medicare billing

Part B allowed, 2024
$288,521
Medicare patients
396
Services billed
5,855

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Levetiracetam16$445
Gabapentin34$333
Tizanidine Hcl25$242

Paid to pharmacies, not to this prescriber.

Other neurological surgery in Reno

See the full list for Nevada

Where these figures come from

Is this you, or does something look wrong? →